📣 Send us your press release
Site updates every 15 minutes
Health

Genetic analysis study shows global applicability of GA-map® Dysbiosis Test

A peer-reviewed study by Genetic Analysis demonstrates that the GA-map® Dysbiosis Test yields consistent results across geographically diverse populations.

16 July 2026
Genetic analysis study shows global applicability of GA-map® Dysbiosis Test
Image is an AI-generated illustration

Genetic Analysis AS (GA) has published a peer-reviewed study in the scientific journal Gut Microbes. The publication shows that the GA-map® Dysbiosis Test produces consistent results when applied to populations from different geographic regions.

The findings address a significant challenge in microbiome diagnostics: population variability. This consistency supports the international applicability of the GA-map® diagnostic platform.

Demonstrating uniform diagnostic performance across diverse geographical areas is crucial for advancing microbiome diagnostics. The study's positive outcomes affirm the reliability of GA-map® technology on a global scale.

This research positions the GA-map® Dysbiosis Test for broader international market adoption. The company intends to continue developing its technology and exploring new applications.

Original source: news.cision.com